10:01 AM EDT, 07/25/2024 (MT Newswires) -- NovoCure ( NVCR ) reported a Q2 loss Thursday of $0.31 per diluted share, narrower than a loss of $0.54 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.40.

Net revenue for the quarter ended June 30 was $150.4 million, up from $126.1 million a year earlier.

Analysts surveyed by Capital IQ expected $135.8 million.

Price: 17.28, Change: -1.51, Percent Change: -8.04